Free Trial
NASDAQ:AEON

AEON Biopharma (AEON) Stock Price, News & Analysis

AEON Biopharma logo
$0.54 -0.05 (-8.88%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$0.55 +0.01 (+0.94%)
As of 05:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About AEON Biopharma Stock (NASDAQ:AEON)

Key Stats

Today's Range
$0.50
$0.58
50-Day Range
$0.48
$10.08
52-Week Range
$0.40
$626.40
Volume
601,030 shs
Average Volume
813,261 shs
Market Capitalization
$5.70 million
P/E Ratio
3.01
Dividend Yield
N/A
Price Target
$360.00
Consensus Rating
Buy

Company Overview

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.

Remove Ads

AEON Biopharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

AEON MarketRank™: 

AEON Biopharma scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AEON Biopharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    AEON Biopharma has received no research coverage in the past 90 days.

  • Read more about AEON Biopharma's stock forecast and price target.
  • Earnings Growth

    Earnings for AEON Biopharma are expected to grow in the coming year, from ($0.77) to ($0.69) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AEON Biopharma is 3.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AEON Biopharma is 3.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.12.

  • Read more about AEON Biopharma's valuation and earnings.
  • Short Interest

    There is no current short interest data available for AEON.
  • Dividend Yield

    AEON Biopharma does not currently pay a dividend.

  • Dividend Growth

    AEON Biopharma does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AEON.
  • News Sentiment

    AEON Biopharma has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for AEON Biopharma this week, compared to 0 articles on an average week.
  • Search Interest

    Only 3 people have searched for AEON on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added AEON Biopharma to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, AEON Biopharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.00% of the stock of AEON Biopharma is held by insiders.

  • Percentage Held by Institutions

    Only 22.78% of the stock of AEON Biopharma is held by institutions.

  • Read more about AEON Biopharma's insider trading history.
Receive AEON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AEON Biopharma and its competitors with MarketBeat's FREE daily newsletter.

AEON Stock News Headlines

Crypto Genius: 12,000% in 12 months? [Here’s how]
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
AEON Biopharma Announces CEO Transition
See More Headlines

AEON Stock Analysis - Frequently Asked Questions

AEON Biopharma's stock was trading at $38.88 at the beginning of 2025. Since then, AEON shares have decreased by 98.6% and is now trading at $0.5409.
View the best growth stocks for 2025 here
.

Shares of AEON Biopharma reverse split on the morning of Wednesday, February 26th 2025. The 1-72 reverse split was announced on Monday, February 24th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 25th 2025. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

AEON Biopharma (AEON) raised $75 million in an initial public offering on Thursday, October 14th 2021. The company issued 5,000,000 shares at $14.00-$16.00 per share.

Shares of AEON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AEON Biopharma investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Jabil (JBL), Disc Medicine (IRON), e.l.f. Beauty (ELF) and Adobe (ADBE).

Company Calendar

Today
4/03/2025
Next Earnings (Estimated)
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AEON
Previous Symbol
NASDAQ:AEON
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$360.00
High Stock Price Target
$360.00
Low Stock Price Target
$360.00
Potential Upside/Downside
+66,455.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
3.01
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-36,630,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($4.12) per share
Price / Book
-0.13

Miscellaneous

Free Float
74,373,000
Market Cap
$5.70 million
Optionable
Not Optionable
Beta
0.26
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:AEON) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners